Skip to main content
Download PDF
Download ePub

Quality of life assessment instruments in children and adolescents with neuromuscular diseases: a systematic scoping review

Health and Quality of Life Outcomes volume 22, Article number: 18 (2024) Cite this article

Abstract

Objective

(1) To identify instruments used to assess quality of life (QoL) in children and adolescents with neuromuscular diseases; (2) To identify the psychometric properties contained in these instruments.

Methods

This is a scoping review in which the electronic databases Embase, Scielo, Scopus, Pubmed and Lilacs were used as well as grey literature. The following terms were used in the search for articles published in the last 10 years: children, adolescents, neuromuscular disease, and quality of life.

Results

In total, 15 articles were included and evaluated, indicating 7 instruments used to assess QoL (PedsQL™ Inventory 3.0 Neuromuscular Module, the PedsQL™ 4.0, the PedsQL DMD Module, the PedsQL ™ MFS, the SOLE, the KIDSCREEN and the LSI-A). The number of items ranged from 17 to 45. In addition, 6 instruments showed psychometric properties, but only 2 showed good and high quality, either in internal reliability or reproducibility.

Conclusion

Our results were able to map the main QoL assessment instruments of children and adolescents with neuromuscular disease and the most cited instrument was the PedsQL™ Inventory 3.0 Neuromuscular Module. Larger studies that assess psychometric properties and that are validated for most diseases are needed.

Introduction

Quality of life (QOL) is defined as “an individual's perception of their position in life in the context of the culture in which they live and in relation to their goals, expectations, standards and concerns” (World Health Organization (WHO) [1]. Some of the elements that can determine QoL are unrelated to health, such as the context of the individual and social relationships (spirituality, family, employment, and friends). Additionally, health-related elements (functional, mental, physical, and emotional well-being) should be highlighted [2]. The WHO concept of QoL is well accepted. However, there is a debate about QoL and health-related quality of life (HRQoL). Thus, HRQoL elucidates the self-perception of well-being aspects that may be related to diseases, symptoms, and treatment [3].

Despite this ongoing conceptual discussion, QoL can vary according to individual experiences [4, 5] with different instruments used to assess relevant information, such as diseases and disabilities and treatment effectiveness [3].

In children and adolescents with disabilities, QoL assessment has been widely used to identify facilitators and barriers and to select individualized therapeutic approaches [6,7,8].

However, QoL assessments need to include aspects of holistic well-being and not be limited to health aspects. QoL and the International Classification of Functioning, Disability, and Health (ICF) are connected since their base is a dynamic model that informs different aspects of the life of an individual with a disability [8, 9].

For children and adolescents with disabilities, incorporating the concepts of F-words (function, family, fitness, fun, friends, and future) in the context of the ICF reinforces the need to consider participation [10]. In this way, it is clear that the concept of QoL is contained in the F-words, and completes the health professionals’ approach [8, 10].

In neuromuscular diseases (NMDs), QoL remains compromised despite technological advances and improvements in drug treatments [11, 12]. NMDs are a set of conditions that can be hereditary and progressive with the involvement of one or more components, such as anterior horn cells, motor units, motor neurons, peripheral nerve, neuromuscular junction, and/or muscle [13,14,15]. In general, NMDs present muscle weakness, fatigue, respiratory problems, and scoliosis, which generate disabilities and directly affect daily activities, participation, and QoL [13, 14, 16]. The most common pediatric NMDs include Charcot-Marie-Tooth disease (incidence of one in 2,500 individuals), Duchenne muscular dystrophy (incidence of one in 3,500 boys), and spinal muscular atrophy (incidence of one in 10,000 individuals) [17, 18].

It is essential to investigate QoL given the severity of neuromuscular diseases and the impacts caused to the patient and the family, depending on the environment and culture [19]. In this context, QoL can be an indicator of the therapies’ effects and it can be used to make professional decisions [20].

Recently, several studies have mentioned QoL as an outcome in rehabilitation assessment and intervention [2, 16, 21,22,23,24,25]. However, there is limited knowledge regarding specific QoL assessment tools for the pediatric population, children, and adolescents with NMDs. Therefore, this study has mapped QoL instruments from the last 10 years that have been used in pediatric neuromuscular diseases. Secondarily, this study has explored information about the psychometric properties of the instruments.

Methodology

Structure of the study

To ensure the originality of this scoping review, the major databases have been consulted (PubMed, Cochrane Database of Systematic Reviews, and PROSPERO). This study was registered with Open Science Framework (https://doi.org/10.17605/OSF.IO/6J9PZ.).

Search strategies and databases

This study was conducted according to methodology proposed by the Joanna Briggs Institute Reviewer's Manual [26]. The guiding question was defined as, "What are the most widely used instruments in the world to assess the quality of life of children and adolescents with neuromuscular diseases? Which of these instruments are validated by the pediatric population?".

To answer this question, the acronym PCC was used to scope review: Participants (children and adolescents with neuromuscular disease), the Concepts (quality of life), and the Context (health).

For the extraction of descriptors, the vocabularies were consulted in the search tools DeCs (Descriptors in Health Sciences) and MeSH (Medical Subject Headings). The descriptors used were: Children, child, infant, adolescents, teenager, neuromuscular disease, neuromuscular disorder, neuromuscular and quality of life and the Boolean terms AND and OR were used to compose the search keys (Supplementary material 1).

The searches took place in July, August and September 2022, and were conducted in 6 electronic databases: Embase, Scielo, Scopus, Pubmed, and Lilacs. Gray literature was searched on Google and Google Scholar, using the same descriptors and pdf type files.

Eligibility

The eligibility assessment involves both the screening and the confirmation of the articles obtained in the searches [26]. For this, it is necessary to choose some criteria, which were determined according to the characteristics of the acronym PCC. Articles should focus on children and adolescents with NMDs and tools that address patient and caregiver perspectives on QoL.

Therefore, experimental, descriptive and observational articles, published in English, Portuguese and Spanish in the last ten years (2012 to 2022), addressing the quality of life of children and adolescents (age 0 to 18 years) with clinical diagnosis of neuromuscular disease were included.

The excluded studies were those focused on different age groups (adults and children), those that investigated the QoL of the caregiver and/or family but not the patient, those that provided limited information regarding the QoL instrument, those related to cancer diagnosis, as well as unpublished dissertations, clinical trials of medications/therapies, and surgeries (pre- and post-operative).

Data screening and extraction

The screening process consists of surveying, organizing and compiling all the results obtained from the databases. For this, the Mendeley Reference Manager tool was used to merge all the search results and remove duplicates.

Data screening was conducted by two reviewers (KLTC and ICSS) independently, and they first read the titles and abstracts of the articles. Subsequently, they selected articles for reading considering the eligibility criteria listed above. Then, an excel spreadsheet was created containing the main data of each study: (I) Characteristics of the study (title, author, year of publication, language, country of origin, type of study, objective); (II) Characteristic of the sample age, neuromuscular clinical diagnosis, sample size; (III) Characteristic of the QoL instrument (instrument, components, form of application, score/stratification and quality of life outcome). Disagreements and doubts were resolved by a third reviewer (CRJAB).

Results

Characteristics of the studies

One thousand seven hundred and eighty-six (1786) articles were identified in the databases and 72 articles were selected, following the eligibility criteria. Among the 72 articles that had a full reading, 15 were included in this review (publications between 2012 to 2022, according to Fig. 1). The types of studies found were: 1 cross-sectional observational [27], 1 cohort [28], 1 prospective longitudinal multicenter cohort [29], 2 cross-sectional [30, 31], 1 cross-sectional descriptive [32], 1 observational, analytic and prospective [33], and 8 unreported [34,35,36,37,38,39,40,41].

Fig. 1
figure 1

Flowchart of information from the phases of the systematized scope-type review

Full size image

Country of origin of the studies

The studies were conducted in several countries, including 3 articles in the USA [28, 34, 40], 2 in China [35, 41], 2 in Italy [29, 38], 2 in Thailand [30, 31], 1 in Argentina [33], 1 in Brazil [40], 1 in Chile [27], 1 in Iran [39], 1 in the Czech Republic [36], and 1 in Turkey [32].

Participants and sample

The number of participants assessed in the studies ranged from 35 [36] to 221 [39], and the participants were between 2 and 18 years old.

Of the scientific articles that composed this review, 8 studies were developed exclusively with patients who had Duchenne muscular dystrophy (DMD) [28, 29, 31, 34, 35, 39, 41]; 2 studies were developed with patients who had spinal muscular atrophy (SMA) types I, II and III [27, 36]; one study consisting of patients with DMD and Becker muscular dystrophy [32]; one study with patients with DMD, girdle muscular dystrophy and spinal muscular atrophy [40]; one study with patients with DMD, spinal muscular atrophy, Charcot-Marie-Tooth disease, and other neuromuscular diseases [30] and, finally, 2 studies consisting of a collection of NMDs [33, 38] (Table 1).

Table 1 Quality of life instruments (n = 15)
Full size table

Quality of life instruments

In this review 7 different instruments that assessed the quality of life of children and adolescents with neuromuscular diseases were found. The "Pediatric Quality of Life Inventory 3.0 Neuromuscular Module (PedsQL™ 3.0)" was used in six (n = 6) studies [27, 29, 30, 33, 35, 36] and the "Pediatric Quality of Life Inventory TM 4.0 (PedsQL™ 4.0)" was also used in other six (n = 6) [28, 29, 32, 34, 37, 41] studies. The first instrument consists of 25 items and the second instrument consists of 23 items. The other instruments were used in single studies: the DMD Module of the Pediatric Quality of Life (PedsQL™) [31], PedsQL™ MFS [29], SOLE questionnaire [38], KIDSCREEN [39], and Life Satisfaction Index for Adolescents (LSI-A) scale [40] (Fig. 2).

Fig. 2
figure 2

Mapping results on quality-of-life instruments in children and adolescents with neuromuscular disease

Full size image

Instrument domains

According to Table 2, the number of items contained in each instrument ranged from 17 to 45. The common domains among the instruments [28,29,30, 34, 40, 41] are physical, social, and psychological. The PedsQL 3.0 [27, 29, 30, 33, 35, 36] looks at disease, communication and family resources. The PedsQL™ Inventory 4.0 Neuromuscular Module and the PedsQL 4.0 Generic Core Scales [28, 29, 34, 37, 41] also include domain on school aspects. The PedsQL DMD Module [31] investigates barriers to treatment. And the PedsQL™ MFS [29] checks fatigue symptoms, with domains regarding sleep and rest fatigue, general fatigue, and cognitive fatigue. The KIDSCREEN [39] looks at domains of autonomy and relationship with parents, as well as social support. The LSI-A, finally, explores the child's personal satisfaction, leisure, and recreation [40].

Table 2 Characteristics of instrument reliability and validity
Full size table

Instrument reliability and validity

Only 6 studies [30, 31, 33,34,35, 40] provided figures on reliability and validity. Three studies used the PedsQL™ Inventory 3.0 Neuromuscular Module questionnaire [30, 33, 35] and showed reasonable internal reliability (Cronbach's alpha ≥ 0.7) [43], stability reliability (test and retest) considered satisfactory (ICC 0.69–0.82 [30]; ICC 0.66–0.88 [35]; ICC 0.67–0.87 [33]) [44] and content validity [30, 33]. The study that used the Pediatric Quality of Life Generic Core Scale (PedsQL™ 4.0) [34] also described reasonable internal reliability (Cronbach's alpha ≥ 0.7), satisfactory stability reliability (ICC 0.74–0.88) with content validity. The study that used the LSI-A instrument [40] showed good internal reliability (Cronback's alpha ≥ 0.87) and satisfactory reproducibility (ICC = 0.69–0.80). Finally, the study that used the PedsQL™ DMD Module instrument [31] obtained satisfactory reproducibility (ICC 0.74–0.88) and showed content validity (Table 2).

Discussion

This study revealed 7 instruments used to assess QoL in children and adolescents with NMD that were similar in some domains [28, 29, 31, 38, 39, 45, 46], two of which showed good reliability and validity. The neuromuscular disease with the greatest coverage in terms of QoL scales was DMD. The instrument with the highest frequency of use and applicable in the multiple pathological conditions was PedsQl [27, 29, 31, 32, 37, 42].

The different QoL assessment tools were applied to children and adolescents with neuromuscular diseases of various etiologies such as SMA [27, 30, 33, 36, 38, 46], DMD [28,29,30,31,32,33, 35, 37, 39, 41, 42, 46] and girdle dystrophies [46] and Charcot-Marie-Tooth disease [30]. Heterogeneous clinical presentations and age are factors to be considered in the choice of the QoL assessment tools. The instruments are available for children from two to six years old, who have demonstrated the ability to understand and self-report information about different aspects of their lives, independently [47, 48]. Similarly, children with asthma were aware of their disease and disabilities and could infer aspects of psychological and social nature [49]. Hospitalized children were also investigated and exhibited the ability to evaluate issues related to their lives [50]. However, almost all agreement between the self-reports of caregivers and the children is poor, with the latter having a more positive view about the QoL [38, 51,52,53]. These data reinforce the relevance of analyzing both the children’s and the caregivers’ perspectives.

Regarding psychometric properties, it is worth highlighting that PedsQL™ 4.0 was cross-culturally adapted in several countries [53,54,55,56,57,58]. Its Brazilian version applied to children with rheumatic diseases and healthy children [53] showed good reliability and validity, similarly to the original American version [55, 59, 60]. The correlation analysis between patients' and parents' answers ranged from moderate to weak (r = 0.77 for the physical dimension; r = 0.73 for the school dimension, and r = 0.49 for the emotional dimension and r = 0.59 for the social dimension) [53].

Agreement between parents and children also seems to be low in other versions of PEDSQL [52] and in other tools [38, 51]. A French study using PEDSQL 3.0 found that caregivers scored worse QoL than the DMD children [52]. In contrast, the PedsQL™ MFS applied to Turkish children with DMD and their parents showed moderate to strong agreement (ICC 0.84–0.91). It is worth highlighting that the PedsQL™ MFS version was reliable for assessing a relevant clinical symptom: the perception of fatigue [61].

Finally, the SOLE and LSI-A are instruments aimed at assessing QoL in the various NMDs. The SOLE proved to be a valid and reliable instrument, with good agreement (Pearson's correlation coefficient 0.365; p < 0.001) when compared to PEDSQL results for children born premature and typical [62]. The LSI-A has been shown to be sensitive to perceived changes in QoL [46, 63]. In children with DMD, the LSI-A instrument proved to be efficient in the qualification and quantification for its coverage of the various domains [40] including identifying limitations in physical condition, activities and social participation [64].

Based on the information obtained in this review, there are specific instruments to evaluate the QoL of the pediatric population with neuromuscular diseases. There is no tool that covers all domains of interest for a certain neuromuscular disease, i.e. fatigue is an item that appears in the PedsQL™ MFS [29] and children's personal satisfaction, leisure, and recreation only appear in the LSI-A [46]. Therefore, it is not possible to recommend one tool over another. According to our understanding, the clinician or researcher should select the assessment tool that presents robust psychometric properties and, if necessary, combine information of tools whose domains complement each other.

Strengths and limitations of the study

This study has strengths: (a) it identified quality-of-life assessment tools focused on children and adolescents with neuromuscular diseases strictly outpatient; (b) the search process considered the main and most accessed electronic databases, including the gray literature, enabling a greater volume of articles consulted; (c) available data about the psychometric proprieties were described.

As limitations, the following can be listed: (1) studies in languages other than English, Spanish, and Portuguese were not included; (2) from the set of selected articles, only 6 articles provided data on the psychometric properties and may not reflect the best instruments for understanding the QoL of children and adolescents with neuromuscular disease.

Recommendations

Considering the current view of QoL, a holistic indicator of the individual, the diversity of clinical presentations of pediatric NMD and the limited number of studies that evaluated QoL in this population, it is relevant that more scientific studies address this issue and focus on the analysis of the instruments’ psychometric properties.

Conclusion

The results of this review suggest that the PedsQL™ DMD Module and LSI-A stood out as being the most suitable instruments to assess the QoL of children and adolescents with DMD, girdle dystrophies, and SMA, taking into account their psychometric properties. However, such instruments have not been tested in other myopathies and neuropathies.

The main contribution of this review is to gather the available instruments capable of investigating QoL in children/adolescents with neuromuscular diseases that are easy to apply and low cost, and sensitive to patients and caregivers/parents.

Availability of data and materials

The datasets supporting the conclusions of this study is available from the corresponding author upon reasonable request.

References

  1. The World Health Organization quality of life assessment (WHOQOL): Position paper from the World Health Organization. Soc Sci Med. 1995;41:1403–9. Available from: https://www.sciencedirect.com/science/article/pii/027795369500112K. [Cited 2023 Jul 18].

  2. Burns TM, Graham CD, Rose MR, Simmons Z. Quality of life and measures of quality of life in patients with neuromuscular disorders. Muscle Nerve. 2012;46:9–25. Available from:  https://onlinelibrary.wiley.com/doi/abs/10.1002/mus.23245. [Cited 2023 Nov 5].

    Article  PubMed  Google Scholar 

  3. Mayo NE. ISOQOL Dictionary of Quality of Life and Health Outcomes Measurement. International Society for Quality of Life Research (ISOQOL); 2015.

  4. Wood-Dauphinee S. Assessing quality of life in clinical research: from where have we come and where are we going? J Clin Epidemiol. 1999;52:355–63.

    Article  CAS  PubMed  Google Scholar 

  5. Aburub AS, Khalil H, Al-Sharman A, El-Salem K. Measuring quality of life and identifying what is important to Jordanian living with multiple sclerosis using the Arabic version of the patient-generated index. Physiother Res Int. 2021;26:e1893. Available from:  https://onlinelibrary.wiley.com/doi/abs/10.1002/pri.1893. [Cited 2023 Jun 7]

    Article  PubMed  Google Scholar 

  6. Cella DF, Wiklund I, Shumaker SA, Aaronson NK. Integrating health-related quality of life into cross-national clinical trials. Qual Life Res Int J Qual Life Asp Treat Care Rehabil. 1993;2:433–40.

    Article  CAS  Google Scholar 

  7. Kuspinar A, Mayo NE. Do generic utility measures capture what is important to the quality of life of people with multiple sclerosis? Health Qual Life Outcomes. 2013;11:71. https://doi.org/10.1186/1477-7525-11-71. [Cited 2023 Jun 7].

    Article  PubMed  PubMed Central  Google Scholar 

  8. Davis E, Reddihough D, Murphy N, Epstein A, Reid SM, Whitehouse A, et al. Exploring quality of life of children with cerebral palsy and intellectual disability: What are the important domains of life? Child Care Health Dev. 2017;43:854–60. Available from:  https://onlinelibrary.wiley.com/doi/abs/10.1111/cch.12501. [Cited 2023 Oct 9].

    Article  CAS  PubMed  Google Scholar 

  9. Classificação Internacional de Funcionalidade, Incapacidade e Saúde (CIF). Available from: https://icd.who.int/dev11/l-icf/en. [Cited 2023 Nov 5]

  10. Rosenbaum P, Gorter JW. The ‘F-words’ in childhood disability: I swear this is how we should think! Child Care Health Dev. 2012;38:457–63. Available from:  https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1365-2214.2011.01338.x.  [Cited 2023 Nov 5]

    Article  CAS  PubMed  Google Scholar 

  11. Biggar WD. Duchenne muscular dystrophy. Pediatr Rev. 2006;27:83–8. https://doi.org/10.1542/pir.27-3-83. [Cited 2023 Jun 12].

    Article  PubMed  Google Scholar 

  12. Peña-Longobardo LM, Aranda-Reneo I, Oliva-Moreno J, Litzkendorf S, Durand-Zaleski I, Tizzano E, et al. The Economic Impact and Health-Related Quality of Life of Spinal Muscular Atrophy. An Analysis across Europe. Int J Environ Res Public Health. 2020;17:5640. Available from:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7459726/. [Cited 2023 Jun 7].

    Article  PubMed  PubMed Central  Google Scholar 

  13. McDonald CM. Physical activity, health impairments, and disability in neuromuscular disease. Am J Phys Med Rehabil. 2002;81:S108-20. Available from:  http://journals.lww.com/00002060-200211001-00012.  [Cited 2023 Jun 7].

    Article  PubMed  Google Scholar 

  14. Kennedy RA, Carroll K, McGinley JL, Paterson KL. Walking and weakness in children: a narrative review of gait and functional ambulation in paediatric neuromuscular disease. J Foot Ankle Res. 2020;13:10. Available from:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052968/. [Cited 2023 Jun 7].

    Article  PubMed  PubMed Central  Google Scholar 

  15. Ng SY, Manta A, Ljubicic V. Exercise biology of neuromuscular disorders. Appl Physiol Nutr Metab. 2018;43:1194–206. Available from:  http://www.nrcresearchpress.com/doi/10.1139/apnm-2018-0229. [Cited 2023 Jun 7].

    Article  PubMed  Google Scholar 

  16. Taniguchi JB, Elui VMC, Osorio FL, Hallak JEC, Crippa JAS, Machado-de-Sousa JP, et al. Quality of life in patients with Charcot-Marie-Tooth disease type 1A. Arq Neuropsiquiatr. 2013;71:392–6. Available from:  http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2013000600392&lng=en&tlng=en. [Cited 2023 Jun 7].

    Article  PubMed  Google Scholar 

  17. Deenen JCW, Horlings CGC, Verschuuren JJGM, Verbeek ALM, van Engelen BGM. The epidemiology of neuromuscular disorders: a comprehensive overview of the literature. J Neuromuscul Dis. 2015;2:73–85.

    Article  PubMed  Google Scholar 

  18. Chikkannaiah M, Reyes I. New diagnostic and therapeutic modalities in neuromuscular disorders in children. Curr Probl Pediatr Adolesc Health Care. 2021;51:101033. Available from:  https://linkinghub.elsevier.com/retrieve/pii/S1538544221000882. [Cited 2023 Jun 7].

    Article  PubMed  Google Scholar 

  19. Michel C, Collins C. Pediatric Neuromuscular Disorders. Pediatr Clin North Am. 2020;67:45–57. Available from:  https://www.sciencedirect.com/science/article/pii/S0031395519301270. [Cited 2023 Jun 12].

    Article  PubMed  Google Scholar 

  20. Haraldstad K, Wahl A, Andenæs R, Andersen JR, Andersen MH, Beisland E, et al. A systematic review of quality of life research in medicine and health sciences. Qual Life Res Int J Qual Life Asp Treat Care Rehabil. 2019;28:2641–50.

    Article  CAS  Google Scholar 

  21. Mori L, Schenone C, Cotellessa F, Ponzano M, Aiello A, Lagostina M, et al. Quality of life and upper limb disability in Charcot-Marie-Tooth disease: a pilot study. Front Neurol. 2022;13:964254. Available from:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9581160/. [Cited 2023 Jun 7].

    Article  PubMed  PubMed Central  Google Scholar 

  22. Schorling E, Senn KC, Thiele S, Gumbert L, Krause S, Schreiber-Katz O, et al. Health-related quality of life and satisfaction with german health care services in patients with Charcot-Marie-tooth neuropathy. J Neuromuscul Dis. 2022;9:211–20. https://doi.org/10.3233/JND-210667. [cited 2023 Jun 7].

    Article  PubMed  Google Scholar 

  23. Travlos V, Patman S, Wilson A, Simcock G, Downs J. Quality of life and psychosocial well-being in youth with neuromuscular disorders who are wheelchair users: a systematic review. Arch Phys Med Rehabil. 2017;98:1004-1017.e1. Available from:  https://www.sciencedirect.com/science/article/pii/S0003999316312291. [Cited 2023 Nov 5].

    Article  PubMed  Google Scholar 

  24. Omura J, Fuentes M, Bjornson K. Participation in Daily Life: Influence on Quality of Life in Ambulatory Children with Cerebral Palsy. PM R. 2018;10:1185–91. Available from:  https://www.sciencedirect.com/science/article/pii/S1934148218302442. [Cited 2023 Nov 5].

    Article  PubMed  Google Scholar 

  25. Gillison FB, Skevington SM, Sato A, Standage M, Evangelidou S. The effects of exercise interventions on quality of life in clinical and healthy populations; a meta-analysis. Soc Sci Med. 2009;68:1700–10. Available from:  https://www.sciencedirect.com/science/article/pii/S0277953609001063. [Cited 2023 Nov 5].

    Article  PubMed  Google Scholar 

  26. Peters MDJ, Godfrey CM, Khalil H, McInerney P, Parker D, Soares CB. Guidance for conducting systematic scoping reviews. JBI Evid Implement. 2015;13:141. Available from:  https://journals.lww.com/ijebh/Fulltext/2015/09000/Guidance_for_conducting_systematic_scoping_reviews.5.aspx. [Cited 2023 Jun 7].

    Google Scholar 

  27. Vega P, Glisser C, Castiglioni C, Amézquita MV, Quirola M, Barja Yañez S. Calidad de vida en niños y adolescentes con Atrofia Muscular Espinal. Rev Chil Pediatría. 2020;91. Available from: http://revistachilenadepediatria.cl/index.php/rchped/article/view/1443. [Cited 2023 Jun 7].

  28. Bendixen RM, Senesac C, Lott DJ, Vandenborne K. Participation and quality of life in children with Duchenne muscular dystrophy using the International Classification of Functioning, Disability, and Health. Health Qual Life Outcomes. 2012;10:43. Available from:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3358238/.  [Cited 2023 Jun 7].

    Article  PubMed  PubMed Central  Google Scholar 

  29. Messina S, Vita GL, Sframeli M, Mondello S, Mazzone E, D’Amico A, et al. Health-related quality of life and functional changes in DMD: A 12-month longitudinal cohort study. Neuromuscul Disord. 2016;26:189–96. Available from:  https://linkinghub.elsevier.com/retrieve/pii/S0960896616000195.[Cited 2023 Jun 7].

    Article  PubMed  PubMed Central  Google Scholar 

  30. Thongsing A, Suksangkarn Y, Sanmaneechai O. Reliability and validity of the Thai pediatric quality of life inventoryTM 3.0 neuromuscular module. Health Qual Life Outcomes. 2020;18:243. https://doi.org/10.1186/s12955-020-01492-z. [Cited 2023 Jun 7].

    Article  PubMed  PubMed Central  Google Scholar 

  31. Thongsing A, Likasitwattanakul S, Sanmaneechai O. Reliability and validity of the Thai version of the Pediatric Quality of Life inventoryTM 3.0 Duchenne Muscular Dystrophy module in Thai children with Duchenne Muscular Dystrophy. Health Qual Life Outcomes. 2019;17:76. Available from:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6498587/. [Cited 2023 Jun 7].

    Article  PubMed  PubMed Central  Google Scholar 

  32. Köken Ö, Kucur Ö, Taşkiran C, Öztoprak Ü, Genç Sel Ç, Aksoy E, et al. Clinical Features and Quality of Life in Duchenne and Becker Muscular Dystrophy Patients from A Tertiary Center in Turkey. Güncel Pediatri. 2021;19:15–22. Available from:  https://dergipark.org.tr/tr/download/article-file/1693548. [cited 2023 Jun 11].

    Article  Google Scholar 

  33. Mozzoni J, Gómez S, Monges MS, de Castro Pérez MF, Méndez M, Lemme P, et al. Validation of the Pediatric Quality of Life InventoryTM, Neuromuscular Module, version 3.0 in Spanish for Argentina. Arch Argent Pediatr. 2021;119:e286-97.

    PubMed  Google Scholar 

  34. Uzark K, King E, Cripe L, Spicer R, Sage J, Kinnett K, et al. Health-Related Quality of Life in Children and Adolescents With Duchenne Muscular Dystrophy. Pediatrics. 2012;130:e1559-66. Available from:  https://publications.aap.org/pediatrics/article/130/6/e1559/30378/Health-Related-Quality-of-Life-in-Children-and. [Cited 2023 Jun 11].

    Article  PubMed  Google Scholar 

  35. Hu J, Jiang L, Hong S, Cheng L, Kong M, Ye Y. Reliability and validity of the Chinese version of the pediatric quality of life inventoryTM (PedsQLTM) 3.0 neuromuscular module in children with Duchenne muscular dystrophy. Health Qual Life Outcomes. 2013;11:47. Available from:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3606306/. [Cited 2023 Jun 7].

    Article  PubMed  PubMed Central  Google Scholar 

  36. Kocova H, Dvorackova O, Vondracek P, Haberlova J. Health-related quality of life in children and adolescents with spinal muscular atrophy in the Czech Republic. Pediatr Neurol. 2014;50:591–4. Available from:  https://linkinghub.elsevier.com/retrieve/pii/S0887899414000642. [Cited 2023 Jun 7].

    Article  PubMed  Google Scholar 

  37. Lim Y, Velozo C, Bendixen RM. The level of agreement between child self-reports and parent proxy-reports of health-related quality of life in boys with Duchenne muscular dystrophy. Qual Life Res Int J Qual Life Asp Treat Care Rehabil. 2014;23:1945–52. Available from:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4140965/. [Cited 2023 Jun 7].

    Article  Google Scholar 

  38. Orcesi S, Ariaudo G, Mercuri E, Beghi E, Rezzani C, Balottin U. A New Self-Report Quality of Life Questionnaire for Children With Neuromuscular Disorders: Presentation of the Instrument, Rationale for Its Development, and Some Preliminary Results. J Child Neurol. 2014;29:167–81. Available from: http://journals.sagepub.com/doi/10.1177/0883073813511859. [Cited 2023 Jun 11].

    Article  PubMed  Google Scholar 

  39. Zamani G, Heidari M, Azizi Malamiri R, Ashrafi MR, Mohammadi M, Shervin Badv R, et al. The quality of life in boys with Duchenne muscular dystrophy. Neuromuscul Disord. 2016;26:423–7. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0960896616300268.[ Cited 2023 Jun 7].

    Article  PubMed  Google Scholar 

  40. Simon VA, Zanoteli E, Simon MAVP, Resende MBDD, Reed UC. Translation and validation of the Life Satisfaction Index for Adolescents scale with neuromuscular disorders: LSI-A Brazil. Arq Neuropsiquiatr. 2017;75:553–62. Available from: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2017000800553&lng=en&tlng=en. [Cited 2023 Jun 11].

    Article  PubMed  Google Scholar 

  41. Liang R, Chan SHS, Ho FKW, Tang OC, Cherk SWW, Ip P, et al. Health-related quality of life in Chinese boys with Duchenne muscular dystrophy and their families. J Child Health Care. 2019;23:495–506. https://doi.org/10.1177/1367493519857423. [cited 2023 Jun 7].

    Article  PubMed  Google Scholar 

  42. Uzark K, King E, Cripe L, Spicer R, Sage J, Kinnett K, et al. Health-related quality of life in children and adolescents with Duchenne muscular dystrophy. Pediatrics. 2012;130:e1559-66. https://doi.org/10.1542/peds.2012-0858. [cited 2023 Jun 7].

    Article  PubMed  Google Scholar 

  43. Pestana H, Gageiro J. ANÁLISE DE DADOS PARA CIÊNCIAS SOCIAIS A Complementaridade do SPSS 6 a EDIÇÃO Revista, Atualizada e Aumentada MARIA HELENA PESTANA JOÃO NUNES GAGEIRO. 2014.

  44. Terwee CB, Bot SDM, de Boer MR, van der Windt DAWM, Knol DL, Dekker J, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol. 2007;60:34–42.

    Article  PubMed  Google Scholar 

  45. Vega P, Glisser C, Castiglioni C, Amézquita MV, Quirola M, Barja Yañez S. Calidad de vida en niños y adolescentes con Atrofia Muscular Espinal. Rev Chil Pediatría. 2020;91. Available from: http://revistachilenadepediatria.cl/index.php/rchped/article/view/1443. [Cited 2023 Jun 11].

  46. Simon VA, Zanoteli E, Simon MAVP, de Resende MBD, Reed UC. Translation and validation of the Life Satisfaction Index for Adolescents scale with neuromuscular disorders: LSI-A Brazil. Arq Neuropsiquiatr. 2017;75:553–62. Available from: https://www.scielo.br/j/anp/a/gPJ8YR58S7VXxQYjLzZfTNR/?lang=en.  [Cited 2023 Jun 7].

    Article  PubMed  Google Scholar 

  47. Riley AW. Evidence that school-age children can self-report on their health. Ambul Pediatr. 2004;4:371–6. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1530156705603279.[Cited 2023 Jun 11].

    Article  PubMed  Google Scholar 

  48. Cremeens J, Eiser C, Blades M. Characteristics of health-related self-report measures for children aged three to eight years: a review of the literature. Qual Life Res. 2006;15:739–54. https://doi.org/10.1007/s11136-005-4184-x. [cited 2023 Jun 11].

    Article  PubMed  Google Scholar 

  49. Harrington KF, Haven KM, Bailey WC, Gerald LB. Provider Perceptions of Parent Health Literacy and Effect on Asthma Treatment Recommendations and Instructions. Pediatr Allergy Immunol Pulmonol. 2013;26:69–75. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678582/. [Cited 2023 Jun 11].

    Article  PubMed  PubMed Central  Google Scholar 

  50. Perosa GB, Gabarra LM. Explanations proffered by children hospitalized due to illness: implications for communication between healthcare professionals and patients. Interface - Comun Saúde Educ. 2004;8:135–48. Available from: https://www.scielo.br/j/icse/a/rMNhHvxTD68dNXxgT3YXhyp/abstract/?lang=en. [Cited 2023 Nov 10].

    Article  Google Scholar 

  51. Ungar WJ, Mirabelli C, Cousins M, Boydell KM. A qualitative analysis of a dyad approach to health-related quality of life measurement in children with asthma. Soc Sci Med. 1982;2006(63):2354–66.

    Google Scholar 

  52. Wallach E, Ehlinger V, Biotteau M, Walther-Louvier U, Péréon Y, Vuillerot C, et al. Confirmatory Validation of the French Version of the Duchenne Muscular Dystrophy Module of the Pediatric Quality of Life Inventory (PedsQL TM 3.0DMDvf). In Review; 2022. Available from: https://www.researchsquare.com/article/rs-1877212/v2

  53. Klatchoian DA, Len CA, Terreri MTRA, Silva M, Itamoto C, Ciconelli RM, et al. Qualidade de vida de crianças e adolescentes de São Paulo: confiabilidade e validade da versão brasileira do questionário genérico Pediatric Quality of Life InventoryTM versão 40. J Pediatr (Rio J). 2008;84:308–15. Available from: https://www.scielo.br/j/jped/a/MmxgFM7hJfBm5Wpf67rmTPf/?lang=pt. [Cited 2023 Nov 8].

    Article  PubMed  Google Scholar 

  54. Sawyer MG, Whitham JN, Roberton DM, Taplin JE, Varni JW, Baghurst PA. The relationship between health-related quality of life, pain and coping strategies in juvenile idiopathic arthritis. Rheumatol Oxf Engl. 2004;43:325–30.

    Article  CAS  Google Scholar 

  55. Felder-Puig R, Frey E, Proksch K, Varni JW, Gadner H, Topf R. Validation of the German version of the Pediatric Quality of Life Inventory (PedsQL) in childhood cancer patients off treatment and children with epilepsy. Qual Life Res Int J Qual Life Asp Treat Care Rehabil. 2004;13:223–34.

    Article  CAS  Google Scholar 

  56. Upton P, Eiser C, Cheung I, Hutchings HA, Jenney M, Maddocks A, et al. Measurement properties of the UK-English version of the Pediatric Quality of Life Inventory 4.0 (PedsQL) generic core scales. Health Qual Life Outcomes. 2005;3:22.

    Article  PubMed  PubMed Central  Google Scholar 

  57. Reinfjell T, Diseth TH, Veenstra M, Vikan A. Measuring health-related quality of life in young adolescents: reliability and validity in the Norwegian version of the Pediatric Quality of Life Inventory 4.0 (PedsQL) generic core scales. Health Qual Life Outcomes. 2006;4:61.

    Article  PubMed  PubMed Central  Google Scholar 

  58. Chen X, Origasa H, Ichida F, Kamibeppu K, Varni JW. Reliability and validity of the Pediatric Quality of Life Inventory (PedsQL) Short Form 15 Generic Core Scales in Japan. Qual Life Res Int J Qual Life Asp Treat Care Rehabil. 2007;16:1239–49.

    Article  Google Scholar 

  59. Varni JW, Seid M, Kurtin PS. PedsQLTM 4.0: Reliability and Validity of the Pediatric Quality of Life InventoryTM Version 4.0 Generic Core Scales in Healthy and Patient Populations. Med Care. 2001;39:800–12. Available from:  http://journals.lww.com/00005650-200108000-00006. [cited 2023 Jun 11]

    Article  CAS  PubMed  Google Scholar 

  60.  Varni JW, Burwinkle TM, Katz ER, Meeske K, Dickinson P. The PedsQLTM in pediatric cancer. Cancer. 2002;94:2090–106. Available from:  https://onlinelibrary.wiley.com/doi/abs/10.1002/cncr.10428.  [Cited 2023 Jun 11].

    Article  PubMed  Google Scholar 

  61.  Alemdaroglu-Gürbüz I, Bulut N, Bozgeyik S, Ulug N, Arslan SS, Yilmaz Ö, et al. Reliability and validity of the turkish translation of pedsqlTM multidimensional Fatigue scale in Duchenne Muscular Dystrophy. Neurosci. 2019;24:302–10. Available from:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8015545/.  [Cited 2023 Jun 11].

    Google Scholar 

  62. Olivieri I, M Bova S, Fazzi E, Ricci D, Tinelli F, Montomoli C, et al. Patient-reported outcomes measure for children born preterm: validation of the SOLE VLBWI Questionnaire, a new quality of life self-assessment tool. Dev Med Child Neurol. 2016;58:957–64. Available from:  https://onlinelibrary.wiley.com/doi/abs/10.1111/dmcn.13122. [Cited 2023 Jun 11].

    Article  PubMed  Google Scholar 

  63. Solans M, Pane S, Estrada MD, Serra-Sutton V, Berra S, Herdman M, et al. Health-related quality of life measurement in children and adolescents: a systematic review of generic and disease-specific instruments. Value Health. 2008;11:742–64. Available from:  https://linkinghub.elsevier.com/retrieve/pii/S1098301510605529. [Cited 2023 Jun 11].

    Article  PubMed  Google Scholar 

  64. Bray P, Bundy AC, Ryan MM, North KN, Burns J. Health status of boys with Duchenne muscular dystrophy: a parent’s perspective: Health status in Duchenne muscular dystrophy. J Paediatr Child Health. 2011;47:557–62. Available from:  https://onlinelibrary.wiley.com/doi/10.1111/j.1440-1754.2011.02022.x. [Cited 2023 Jun 11].

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) and the Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP).

Funding

This work was supported by Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) [grants 8887.817059/2023–00] and by the Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) (grant 17596–4/2017).

Author information

Authors and Affiliations

  1. Department of Health Science, Ribeirão Preto Medical School, University of São Paulo, Av. Miguel Covian, 120, Ribeirão Preto, São Paulo, 14.049-900, Brazil

    Karoliny Lisandra Teixeira Cruz, Isadora Cristina Sousa Santos, Cyntia Rogean de Jesus Alves de Baptista & Ana Claudia Mattiello-Sverzut

Authors
  1. Karoliny Lisandra Teixeira Cruz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Isadora Cristina Sousa Santos
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Cyntia Rogean de Jesus Alves de Baptista
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ana Claudia Mattiello-Sverzut
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Material preparation [Karoliny Lisandra Teixeira Cruz], [Ana Claudia Mattiello-Sverzut] data collection and analysis were performed by [Karoliny Lisandra Teixeira Cruz], [Isadora Cristina Souza Santos] and [Cyntia Rogean Jesus Alves de Baptista]. The first draft of the manuscript was written by [Karoliny Lisandra Teixeira Cruz], [Ana Claudia Mattiello-Sverzut] and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Ana Claudia Mattiello-Sverzut.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cruz, K.L.T., Santos, I.C.S., de Jesus Alves de Baptista, C.R. et al. Quality of life assessment instruments in children and adolescents with neuromuscular diseases: a systematic scoping review. Health Qual Life Outcomes 22, 18 (2024). https://doi.org/10.1186/s12955-024-02232-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12955-024-02232-3

Keywords

Health and Quality of Life Outcomes

ISSN: 1477-7525

Contact us